Neogen (NEOG) Non-Current Deferred Tax Liability (2011 - 2026)
Neogen (NEOG) posted quarterly Non-Current Deferred Tax Liability of $257.6 million for Q2 2026, down 8.29% year-over-year from $280.9 million in Q2 2025, and down 4.31% quarter-over-quarter from $269.2 million in Q1 2026.
Neogen (NEOG) Non-Current Deferred Tax Liability (2011 - 2026) Analysis & Trends
Neogen's Non-Current Deferred Tax Liability history runs 16 years deep, the most recent figure standing at $257.6 million for Q2 2026.
- In Q2 2026, Non-Current Deferred Tax Liability fell 8.29% year-over-year to $257.6 million; the TTM figure through May 2026 stood at $257.6 million (down 8.29% YoY), while the FY2026 annual figure was $257.6 million, down 8.29% from the prior year.
- Non-Current Deferred Tax Liability for Q2 2026 stood at $257.6 million, down from $269.2 million in the prior quarter.
- The five-year high for Non-Current Deferred Tax Liability was $364.3 million in Q4 2022, with the low at $15.9 million in Q3 2022.
- The 5-year median for Non-Current Deferred Tax Liability is $301.7 million (2024), against an average of $266.9 million.
- The sharpest annual moves came in 2022 and 2023: Non-Current Deferred Tax Liability slumped 34.59% in 2022, then surged 2124.54% in 2023.
- Neogen's Non-Current Deferred Tax Liability stood at $364.3 million in 2022, then dropped by 2.54% to $355.0 million in 2023, then fell by 14.82% to $302.4 million in 2024, then decreased by 9.41% to $273.9 million in 2025, then slipped by 5.97% to $257.6 million in 2026.
- Business Quant data shows NEOG's Non-Current Deferred Tax Liability at $257.6 million in Q2 2026, $269.2 million in Q1 2026, and $273.9 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn |
| 10 | Neogen | 2.56 Bn | 2.37 Bn | 107.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | 257.60 Mn |
| May 31, 2026 | 257.60 Mn |
| Feb 28, 2026 | 269.20 Mn |
| Feb 28, 2026 | 269.20 Mn |
| Nov 30, 2025 | 273.95 Mn |
| Nov 30, 2025 | 273.95 Mn |
| Aug 31, 2025 | 277.25 Mn |
| Aug 31, 2025 | 277.25 Mn |
| May 31, 2025 | 280.90 Mn |
| May 31, 2025 | 280.90 Mn |
| Feb 28, 2025 | 301.05 Mn |
| Feb 28, 2025 | 301.05 Mn |
| Nov 30, 2024 | 302.41 Mn |
| Nov 30, 2024 | 302.41 Mn |
| Aug 31, 2024 | 317.57 Mn |
| Aug 31, 2024 | 317.57 Mn |
| May 31, 2024 | 326.72 Mn |
| May 31, 2024 | 326.72 Mn |
| Feb 29, 2024 | 353.85 Mn |
| Feb 29, 2024 | 353.85 Mn |